Literature DB >> 6194216

Activation of nonspecific killer cells by interleukin 2-containing supernatants.

H S Teh, M Yu.   

Abstract

In the absence of specific antigen stimulation, nonspecific killer cells were induced by culturing C57BL/6 lymph node or spleen cells with interleukin 2-containing supernatants. These supernatants were obtained from stimulation of either rat spleen cells with concanavalin A or a variant of the T cell lymphoma, EL4 (H-2b) with phorbol myristic acetate. The ability of the EL4 supernatant to induce nonspecific killer cells was abrogated by absorption with an interleukin 2-dependent T cell line or by concanavalin A-stimulated spleen cell blasts, but not by lipopolysaccharide-stimulated spleen cell blasts or by a non-interleukin 2-producing EL4 line. Partially purified interleukin 2 from EL4 supernatants could also support nonspecific killer cell induction. The induction of cytolytic cells by interleukin 2 is sensitive to gamma-irradiation and has a D omicron of 120 rad. The nonspecific killer cells induced are likely cytotoxic T lymphocytes; the majority of the precursor and effector cells bear the Thy-1 alloantigen marker. These nonspecific killer cells killed a broad spectrum of target cells, including concanavalin A- and lipopolysaccharide-induced splenic blasts of syngeneic or allogeneic mice, a syngeneic tumor, and a cloned allogeneic cytotoxic T cell line. The frequency of precursors for nonspecific killer cells in C57BL/6 lymph node and spleen cells are 1/7000 and 1/12,000, respectively. Clonal analyses revealed that these nonspecific killers exhibit heterogeneity with respect to their target cell specificities. The induction of nonspecific killers by interleukin 2-containing supernatants is partially dependent on nylon wool-adherent cells; in antigen-stimulated cultures the most specific killer cells were obtained from cultures in which nylon wool-nonadherent lymph node responder cells were stimulated with nylon wool-nonadherent allogeneic splenic stimulator cells that were treated with anti-Thy-1 antibody and complement. The relevance of these findings with respect to the frequencies and fine specificities of cytotoxic T lymphocytes generated in interleukin 2-supplemented cultures is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194216

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Licensed to kill.

Authors:  G Cambridge
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11

2.  The augmentation of lymphokine-activated killer cells induced by partial hepatectomy in mice.

Authors:  M Ono; N Tanaka; K Orita
Journal:  Jpn J Surg       Date:  1989-11

3.  Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.

Authors:  F Ronchese; D Collavo; P Zanovello; V Cerundolo; G Biasi
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

Review 4.  Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines.

Authors:  A E Lagarde
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

5.  Lysis of primary hepatic tumours by lymphokine activated killer cells.

Authors:  K H Hsieh; S Y Shu; C S Lee; C T Chu; C S Yang; K J Chang
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

6.  Leukaemia x fibroblast hybrid cells augment the antibody response to sheep red blood cells in inbred mice.

Authors:  E P Cohen; K Hagen
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

7.  Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice.

Authors:  E Kedar; E Chriqui-Zeira; S Mitelman
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  Antigen-independent activation of cytotoxic T cells by lymphokines.

Authors:  L D Williams; W R McMaster; H S Teh
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

9.  Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.

Authors:  R R Salup; R H Wiltrout
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  The use of cytotoxic T cells in the regulation of tumour growth in syngeneic mice.

Authors:  L Kwong; D G Kilburn; H S Teh
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.